Summary. Thrombosthenin, an immunologically distinct contractile protein was isolated in relatively pure form from human platelets. The protein, which was of high molecular weight appeared to be composed of multiple polypeptide subunits, probably polymeric in nature.
Introduction
Certain biochemical and physiological properties of blood platelets suggest that they possess contractile activity similar in some respects to that found in muscle tissue. Clot retraction requires the presence of platelets, and during the formation of a hemostatic plug, platelet aggregates appear to actively contract as part of the phenomenon known as viscous metamorphosis (1) . Actomyosin-like * Submitted for publication November ATPase activity is present in platelets (2) and glycolysis is a major pathway of energy-metabolism (3) . An actomyosin-like protein, thrombosthenin, was first extracted from human platelets by Bettex-Galland and Luscher (2) . A similar protein in pig platelets was extracted and partially characterized by Grette (4) . Of further interest is the description of intracellular contractile proteins in flagellated protozoans, mitochondria, sarcoma cells (5) , and chick embryo fibroblast cells (6) . This report describes the isolation and further characterization of human platelet thrombosthenin. Furthermore, its distribution in specific subcellular compartments will be defined.
Methods
Thrombosthenin preparation. The general procedure utilized to separate thrombosthenin was based mainly on the technique as described by Grette (4) and is patterned after methods employed for the extraction of actomyosin from muscle tissue (7) . The starting ma-terials were platelet concentrates1 prepared from 10-20 units of freshly collected whole blood, using acid-citratedextrose solution as the anticoagulant. Usually the concentrates were processed to the point of butanol extraction on the day of collection. Rarely they were stored at 40 C overnight before processing. Platelets were separated by means of the "oil bottle" centrifugation technique (8) , washed three times in Alsever's solution (9) , and washed three times more in 0.9%o NaCl containing 0.1 volume of 3.14% sodium citrate dihydrate at 40 C. 2 ml of cold 0.6 M KC1 in 0.015 M Tris buffer (pH 7.5) was added to each gram (wet weight) of platelets, followed by 25 pIA of n-butanol for each milliliter of final solution. Lysis of the cells occurred upon the addition of butanol (4) . The extraction proceeded for 24 hr at 40 C, and after being warmed to room temperature the material was centrifuged at 12,100 g for 15 min at 220 C. The supernatant was cooled to 40 C and 2 volumes of cold 0.002 M MgSOs were added. The pH was adjusted to 6.5 with 0.1% acetic acid, and the mixture was kept at 4°C for 1-3 hr, after which it was centrifuged at 8,700 g for 10 min at 40 C. The contractile protein precipitated in the form of a gel and was redissolved in 2 volumes of 0.6 M KC1 in 0.015 M Tris. It was then reprecipitated five times over the following 24- (10) . The concentrations of membrane thrombosthenin solutions were 0.45%o in 0.6 M KCl, 0.015 M Tris (pH 7.5).
Granule thrombosthenin was studied in 0.3%o solutions under the same conditions. The times obtained in each viscosity experiment represent the average of triplicate determinations which were then used to calculate relative viscosity.
Superprecipitation studies. In a low magnesium environment and in the presence of ATP, muscle proteins flocculate and contract to small volume. This phenomenon is known as superprecipitation (2 ATPase experiments. 1 mg of reprecipitated thrombosthenin in a final volume of 1 ml was incubated at 220 C with 5 X 10' M ATP. The medium also included KCl 5 X 10'2 M; MgSO4 1 X 10' M; and borate buffer 0.2 M (pH 7.0) (4). After a 30 min incubation period, the reaction was stopped by the addition of 1 ml of 10%o trichloroacetic acid (TCA) and the mixture allowed to stand for 30 min at room temperature. The tubes were then centrifuged at 3,000 g for 15 min and inorganic phosphorus in the supernatant fraction was determined by the method of Marsh (11 Immunoelectrophoresis and immunodiffusion studies were carried out by methods previously described (12, 13) . Agar was prepared in the presence of 0.6 M KCl.
Clot retraction was evaluated by a modification of the technique of Shulman (14) . Studies on clot retraction inhibition were carried out as follows: tubes containing 0.9 ml of platelet-rich plasma and 0.1 ml of the various antisera were recalcified with 0.1 ml of 0.5 M CaCl2 and incubated at 370 C for 1 hr. Clot retraction inhibition was also studied in a plasma-free system by incubating 0.5 ml of washed platelets in Tris-buffered saline (15) with 0.1 ml of purified fibrinogen (2 g/100 ml) and 0.2 ml of glucose (200 mg/100 ml). 0.1 ml of antiserum was added and the system was clotted with 0.1 ml of thrombin" (10 units in 0.025 M calcium chloride).
Starch urea gel electrophoresis in glycine buffer was carried out by the method of Cohen (16) . Peptide mapping of thrombosthenin purified by column chromatography was performed as previously described (17) . When pronase12 was used for digestion, 2 units of enzyme were added for every 10 mg of protein. The incubation was carried out in 0.2 M sodium bicarbonate (pH 8.0) for 24 hr at 370 C.
Studies on subcellular platelet fractions. The technique for preparing platelet homogenates and their subsequent separation on a continuous sucrose density gradient has been described in detail (18) . Two subcellular "compartments" and the soluble fraction ("cell sap") were studied. Fractions to be used for ATPase experiments were washed in borate buffer (0.2 M, pH 7.0), and those from which thrombosthenin was extracted were washed in citrate-saline solution (4). The granules were washed by ultracentrifugation at 36,220 g for 20 min. The membranes were washed at 198,400 g for 60 min. Prior to ATPase studies, the washed pellets were resuspended in borate buffer and stored overnight in ice or frozen at -85°C. Washed pellets for thrombosthenin extraction were stored at -850 C. The starting material for these extractions was 1.5 -2.7 g (wet weight) of granules and 0.6-1.4 g (wet weight) of membranes.
This was the equivalent of fractions derived from platelets isolated from 5-10 units of whole blood. The extraction procedure was essentially the same as for whole platelet thrombosthenin except for modifications necessitated by the quantity and nature of the material. For each gram (wet weight) of granules, 2 ml of KCl-Tris buffer was added. For comparable membrane material, 3.3 ml of KCl-Tris buffer was added. After the addition of MgSO4, the mixture was kept at 40 C overnight and then centrifuged at 12,100 g for 15 min at 40 C. The resulting precipitate was redissolved in 1-2 ml of KCl-Tris solution and used for ATPase assay. For some viscosity and superprecipitation studies, a single reprecipitation step was carried out. When whole fractions were assayed for ATPase activity, about 1 mg of protein was used. Slightly less was employed when the extracted thrombosthenin was similarly assayed. The ATP concentration in the assay mixture was 1 X 10' M. After the reaction was stopped with cold TCA, the tubes were centrifuged at 10,000 rpm for 15 min at 4°C. Inorganic phosphate in the clear supernate was determined by the method of Dryer, Tammes, and Routh (19) . Tissue blanks, ATP blanks, and reagent blanks were included in all assays.
Protein determinations were carried out by the Folin method (20) . Human striated muscle actomyosin was prepared by the method of Levy and Fleisher (7).
Results

Whole platelet thrombosthenin
Unless otherwise stated, the following results were obtained on thrombosthenin that was sixfold reprecipitated. (Table II) . Deletion of magnesium resulted in a significant but incomplete loss of ATPase activity. Virtually complete inhibition was noted with mersalyl and slight inhibition was found with ouabain. Significant loss of ATPase activity occurred when antithrombosthenin globulin was added to the assay system. Antifibrinogen globulin had no effect on the enzymatic activity of thrombosthenin.
Immunologic studies. A preparation of reprecipitated thrombosthenin, further purified by chromatography, was subjected to immunoelectrophoresis using a potent rabbit antithrombosthenin serum. As shown in Figure 2 , a single precipitin line in the beta globulin region was observed. The procedure was repeated using the thrombosthenin preparation against antifibrinogen, antiwhole human serum, anti-albumin, and anti-gamma globulin. In no instance was reactivity observed. However, when less purified, unchromatographed samples of thrombosthenin were used as antigen, the antiserum to thrombosthenin precipitated two antigens, one of which appeared to be identical with human fibrinogen. The antithrombosthenin in the unadsorbed state thus appeared to have antifibrinogen activity; however in no case did antifibrinogen react with purified preparations of thrombosthenin. Antisera to striated and smooth muscle actomyosin of human origin failed to react with thrombosthenin. Similarly, antithrombosthenin failed to react with a preparation of striated muscle actomyosin. A preparation of washed human platelets was exposed to fluoresceinated antithrombosthenin that had been previously adsorhed with human fibrinogen and normal human plasma. A diffuse, "speckled" type of staining was observed ( Figure  3) . In contrast, erythrocytes and buffy coat preparations were not stained with the antiserum. Intense fluorescence was noted in megakaryocytes in two normal bone marrow preparations.
Clot retraction experiments. The effect of thrombosthenin antiserum on clot retraction of recalcified platelet-rich plasma was examined. A typical experiment is shown in Figure 4 , in which it is seen that antisera to human platelets and thrombosthenin completely inhibited clot retraction. This phenomenon was abolished by prior adsorption of the antisera with thrombosthenin. If the antisera were adsorbed with normal human plasma or purified human fibrinogen, clot retraction inhibition was still observed. No 
FIG. 4. CLOT RETRACTION INHIBITION STUDIES USING CITRATED PLATLET-RICH PLASMA AND VARIOUS ANTISERA.
Calcium was added after 5 min incubation at 370 C.
anti-gamma globulin, anti-whole serum, or antifibrinogen were used. This series of experiments was repeated on four occasions with two separate batches of antisera. Identical results were obtained. Finally, antisera to actomyosin derived from smooth and striated muscle were completely ineffective as inhibitors of clot retraction. In order to determine whether plasma proteins in this system competed with platelets for antiserum binding, thereby masking the potential inhibitory effect of antiserum, we repeated these experiments in a purified fibrinogen (plasma-free) system. No inhibition of clot retraction was observed when anti-gamma globulin or anti-albumin were added to the fibrinogen-platelet mixtures. Antisera which did not inhibit clot retraction remained Figure 5 . Identical results were obtained in three separate experiments. In contrast, antiserum to the soluble fraction present at the top of the sucrose density gradient after ultracentrifugation had no effect on clot retraction. ules and membranes (Table III) . Attempts were then made to distinguish this ATPase activity from that of the sodium-dependent, potassiumstimulated "pump" ATPase. Ouabain produced partial inhibition of the ATPase activity in the granule and membrane fractions, suggesting the presence of "pump" ATPase activity in these particles. However, ouabain had no inhibitory effect on the ATPase activity of the thrombosthenin extracted from the subcellular particles. Mersalyl inhibited the ATPase activity of the subcellular particles and the thrombosthenin extracted from them. None of the inhibitory conditions influenced the ATPase activity of the soluble compartment. The results are summarized in Table IV . Superprecipitation and viscosity. The experiments were performed with thrombosthenin extracted from isolated membranes and granules. Solutions of membrane and granule thrombosthenin showed clear-cut superprecipitation properties in the presence of ATP in two separate batches of extracted material.
Soluble thrombosthenin was extracted from platelet membranes in two separate experiments. The relative viscosity of these preparations was 1.6 and 1.7, respectively. In the presence of ATP (10-3M) there was a moderate fall in relative viscosity (Table V) . In 30 min the relative viscosity returned to the approximate starting values. ATP sensitivity of the membrane thrombosthenin solutions was 48 and 45%o respectively. Soluble thrombosthenin extracted from platelet granules showed similar but less striking changes in viscosity following the addition of ATP.
Immunologic studies. Antithrombosthenin, adsorbed with lyophilized human plasma and human Soluble platelet protein derived from the top layer of the subcellular gradient was dialyzed into 0.6 M KCI and ultrafiltered. The protein concentrations in the antigens were equal. The middle well contained antithrombosthenin adsorbed with fibrinogen and plasma.
fibrinogen, reacted with thrombosthenin preparations from granules, membranes, and whole platelets ( Figure 6 ). The reaction against the soluble subcellular compartment was negligible.
Discussion
There is little doubt that proteins associated with the plasma membrane of the platelet, as well as those located intracellularly, are of great functional significance. In these studies, the contractile protein thrombosthenin was first isolated from whole platelets and subsequently from platelet granules and membranes. A variety of experiments on its in vitro properties were then carried out.
The results corroborate previous reports that thrombosthenin has physicochemical properties similar to those of contractile protein of muscle tissue. The protein was soluble only at relatively high ionic strengths. In the presence of ATP it showed the phenomenon of superprecipitation and underwent reversible alterations in viscosity. The ATP sensitivity of whole platelet thrombosthenin preparations was similar to that reported for actomyosin derived from smooth muscle. In addition, purified thrombosthenin showed magnesium-dependent ATPase activity which was slightly inhibited by ouabain and almost totally inhibited by mersalyl, a mercurial compound which is a specific inhibitor of contractile proteins of the actomyosin group (5). The finding that ouabain exerted a mild inhibitory effect on the ATPase activity of whole platelet thrombosthenin may have reflected contamination of the extracted protein with other ATPase moieties or could have been due to the relatively high concentration of ouabain used in the experiments (10-M). Ouabain at a concentration which completely inhibited "pump" ATPase activity of the subcellular fractions (1O-5 M) had no inhibitory effect on thrombosthenin from these particles. This suggested that the Na-dependent, K-stimulated ATPase activity of platelets was distinct from that associated with thrombosthenin. These experiments were carried out on one batch of extracted subcellular thrombosthenin since qualitative rather than precise quantitative effects were sought, as a means of distinguishing between the types of ATPase activity present. Experiments on the "pump" ATPase of platelets will be reported elsewhere. The physical properties of platelet thrombosthenin closely resembled those of contractile protein extracted from rat sarcoma cells (5) .
The immunologic studies indicated that thrombosthenin could not be detected in normal human plasma or serum and was a protein apparently unique to platelets. Furthermore, there was no cross-reactivity with actomyosin derived from human smooth and striated muscle. In general, the thrombosthenin extracts which were not further purified chromatographically contained varying amounts of platelet fibrinogen and possibly other contaminants. Therefore, the thrombosthenin antisera were adsorbed with fibrinogen and plasma before use. When washed normal human platelets were exposed to previously adsorbed fluoresceinated antithrombosthenin, a diffuse "speckled" type of staining was observed. There did not appear to be a preferential binding of the fluorescein label to the plasma membrane. Similar intense staining was noted in the megakaryocytes of normal bone marrow. The fluoresceinated antiserum did not stain normal leukocytes or erythrocytes, suggesting that it was specific for platelets.
Anti-whole platelet and antithrombosthenin sera completely inhibited clot retraction of recalcified platelet-rich plasma. This inhibitory activity could be completely abolished by adsorption of the antisera with a thrombosthenin extract. Other antisera, particularly antifibrinogen, did not significantly affect the ability of platelets to support clot retraction. Prior adsorption of the thrombosthenin antiserum with either fibrinogen or human plasma did not remove its inhibitory properties. The fact that anti-whole platelet sera inhibited clot retraction, which could be abolished by prior adsorption with extracted thrombosthenin, suggested that this property of anti-whole platelet sera was probably related to a population of thrombosthenin antibodies.
Antisera to the soluble subcellular "compartment" of platelets had no effect on clot retraction. This was taken as further evidence of the specificity of the clot retraction inhibition reaction. The soluble (cell sap) subcellular component did not contain thrombosthenin, but was previously found to contain practically the entire complex of soluble platelet protein (21) . It is possible that the antigen-antibody complex involving thrombosthenin in or on the platelet membrane caused nonspecific damage, thereby destroying other undefined components of the clot retraction system. However, if this were true, one might expect a deleterious effect on clot retraction from other nonspecific immune reactions. No such effects were observed in experiments with anti-albumin, antiIgG, anti-whole serum and antifibrinogen. AntiIgG and anti-albumin were also ineffective in a plasma-free system, which is significant since albumin and gamma globulin are identifiable in platelets even after extensive washing (22) . Therefore, not all antigen-antibody reactions involving platelet components impair clot retraction. This favors the specificity of the thrombostheninantithrombosthenin reaction. Perhaps immune drug reactions which affect clot retraction may be deleterious to the steric and functional integrity of thrombosthenin.
Since disrupted platelets do not support clot retraction, it would appear that thrombosthenin must retain a specific steric relationship in the cell in order to participate in the retraction process.
Platelet fibrinogen is another necessary component for clot retraction (23) and a recent report by Morse, Jackson, and Conley indicated that enzymatic splitting of fibrinopeptide B from fibrinogen by thrombin is a necessary prerequisite for clot retraction (24) . Clot retraction probably represents the culmination of a complex series of physiological events, requiring at least a source of energy in an intact platelet, proteolytic digestion of platelet fibrinogen, and the presence of the contractile protein thrombosthenin. The capacity of thrombosthenin to hydrolyze ATP may be an important part of its function in mediating clot retraction. The observation that antithrombosthenin significantly blocks the ATPase activity of thrombosthenin suggests that an enzymatic site(s) of the molecule may be necessary for its activity. However, the antiserum probably also contains antibodies to nonenzymatic portions of the molecule. Chambers, Salzman, and Neri have proposed that the ATPase activity of thrombosthenin on the outer platelet membrane may be related to the action of ADP in aggregating platelets (25) .
Our structural studies on purified thrombosthenin suggest that the molecule may be composed of subunit polypeptide chains, possibly of polymeric nature as illustrated by multiple bands in starch urea gel electrophoresis. The molecular weight was greater than 300,000, as evidenced by exclusion of the active material by a P-300 Bio-Gel column. It was of interest that only eight peptides were identifiable after tryptic digestion of the purified protein. Pronase digestion revealed 12-13 spots on fingerprinting, which was in marked contrast to over 40 spots when striated muscle actomyosin was similarly treated. The small number of peptides in the presence of a large molecular weight suggests the presence of repeating units.
Studies on the subcellular platelet fractions indicated that thrombosthenin was associated with platelet granules and membranes. Anti-granule and anti-membrane sera, previously adsorbed with fibrinogen' and human plasma, inhibited clot retraction. Furthermore, it was possible to directly extract KCl-soluble, magnesium-precipitable protein from isolated granules and membranes. This material showed potent ATPase activity partially inhibited by mersalyl and not inhibited by ouabain. In similar fashion, the isolated granules and membranes themselves actively hydrolyzed ATP. That these fractions contained other ATPase activities such as the cation "pump" was evident by partial inhibition of enzyme activity by ouabain. The specific activity of the extracted subcellular thrombosthenin was greater than that associated with the whole particle fractions (Table III) . It appeared that thrombosthenin derived from the platelet membrane was more active than that extracted from the granules. These materials reacted strongly with the adsorbed antithrombosthenin serum. The granule thrombosthenin showed two to three precipitin lines with the antiserum, while whole platelet and membrane thrombosthenin showed single precipitin arcs in agar. Both the granule and membrane thrombosthenin underwent superprecipitation in the presence of ATP and ATP caused reversible changes in their relative viscosity (Table V) . However, these changes were less marked than those observed with whole platelet thrombosthenin, possibly due to the intricate series of manipulations involved in processing the material as well as to its inherent lability (2) . In general, the properties of thrombosthenin extracted from the membranes more closely resembled those of whole platelet thrombosthenin than did the granule preparation. The reasons for these differences are not clear, but it is possible that hydrolytic enzymes known to be present in platelet granules (18) may have altered some of the properties of thrombosthenin during the separation procedure. Finally, the granule thrombosthenin may have contained more contaminants than the membrane thrombosthenin.
The specificity of the subcellular distribution of thrombosthenin may still require further examination. For example, thrombosthenin made available after platelet homogenization might denature, precipitate, and then nonspecifically sediment in the sucrose gradient (22) . However, the absence of extractable thrombosthenin in the soluble (cell sap) layer of the sucrose gradient and its relatively intact physicochemical and immunological character in the subcellular fractions suggest that the protein may be a normal constituent of platelet membranes. The significance of the differences between granule and membrane thrombosthenin noted in the viscosity and immunochemical studies remains to be determined. It is of interest that a contractile protein has recently been isolated from the membrane of liver cells (26) .
